Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy.

Ouzaid I, Yates DR, Hupertan V, Mozer P, Chartier-Kastler E, Haertig A, Bitker MO, Rouprêt M.

Prostate. 2012 Aug 1;72(11):1200-6. doi: 10.1002/pros.22470. Epub 2011 Dec 27.

PMID:
22213470
2.

Head-to-head comparison of two online nomograms for prostate biopsy outcome prediction.

Oliveira M, Marques V, Carvalho AP, Santos A.

BJU Int. 2011 Jun;107(11):1780-3. doi: 10.1111/j.1464-410X.2010.09727.x. Epub 2010 Sep 30.

3.

[Prospective validation of a nomogram predictive of a positive initial prostate biopsy].

Ramírez-Backhaus M, Bahilo P, Arlandis S, Santamaría Navarro C, Pontones Moreno JL, Jiménez-Cruz F.

Actas Urol Esp. 2010 Jan;34(1):35-42. Spanish.

PMID:
20223131
4.

Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme.

Nomura M, Ito K, Miyakubo M, Sekine Y, Tamura Y, Shimizu N, Aoki S, Suzuki K.

Prostate Cancer Prostatic Dis. 2012 Jun;15(2):202-9. doi: 10.1038/pcan.2011.62. Epub 2011 Dec 6.

PMID:
22143446
5.

The outcomes of transrectal ultrasound guided biopsy of the prostate in a New Zealand population.

Lienert AR, Davidson PJ, Wells JE.

N Z Med J. 2009 Jan 23;122(1288):39-49.

PMID:
19182841
6.

Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.

Kawakami S, Numao N, Okubo Y, Koga F, Yamamoto S, Saito K, Fujii Y, Yonese J, Masuda H, Kihara K, Fukui I.

Eur Urol. 2008 Sep;54(3):601-11. doi: 10.1016/j.eururo.2008.01.017. Epub 2008 Jan 15.

PMID:
18207312
7.

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.

Auprich M, Augustin H, Budäus L, Kluth L, Mannweiler S, Shariat SF, Fisch M, Graefen M, Pummer K, Chun FK.

BJU Int. 2012 Jun;109(11):1627-35. doi: 10.1111/j.1464-410X.2011.10584.x. Epub 2011 Sep 21.

8.

Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.

Kawamura K, Suzuki H, Kamiya N, Imamoto T, Yano M, Miura J, Shimbo M, Suzuki N, Nakatsu H, Ichikawa T.

Int J Urol. 2008 Jul;15(7):598-603. doi: 10.1111/j.1442-2042.2008.02058.x. Epub 2008 May 2.

9.

Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.

Karakiewicz PI, Benayoun S, Kattan MW, Perrotte P, Valiquette L, Scardino PT, Cagiannos I, Heinzer H, Tanguay S, Aprikian AG, Huland H, Graefen M.

J Urol. 2005 Jun;173(6):1930-4.

10.
11.

Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.

Roobol MJ, van Vugt HA, Loeb S, Zhu X, Bul M, Bangma CH, van Leenders AG, Steyerberg EW, Schröder FH.

Eur Urol. 2012 Mar;61(3):577-83. doi: 10.1016/j.eururo.2011.11.012. Epub 2011 Nov 15.

PMID:
22104592
13.
14.

Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.

Hansen J, Auprich M, Ahyai SA, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Fisch M, Abbou CC, Schalken JA, Fradet Y, Marks LS, Ellis W, Partin AW, Pummer K, Graefen M, Haese A, Walz J, Briganti A, Shariat SF, Chun FK.

Eur Urol. 2013 Feb;63(2):201-9. doi: 10.1016/j.eururo.2012.07.030. Epub 2012 Jul 20.

PMID:
22854248
15.

Models to predict positive prostate biopsies using the Tyrol screening study.

Sooriakumaran P, John M, Christos P, Bektic J, Bartsch G, Leung R, Herman M, Scherr D, Tewari A.

Urology. 2011 Oct;78(4):924-9. doi: 10.1016/j.urology.2011.05.061. Epub 2011 Aug 16.

PMID:
21840579
16.

[Establishment of a nomogram for predicting positive repeat prostate biopsy in Chinese men].

Li QY, Tang J, Li YM, Fei X, Zhang Y, He EH, Zhou Y.

Zhonghua Nan Ke Xue. 2012 Apr;18(4):302-5. Chinese.

PMID:
22574362
17.

Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocol.

Nicolaiew N, Ploussard G, Chun FK, Xylinas E, Allory Y, Salomon L, de la Taille A.

Urol Int. 2013;90(3):306-11. doi: 10.1159/000345603. Epub 2013 Jan 5.

PMID:
23295308
18.

A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer.

Tang P, Chen H, Uhlman M, Lin YR, Deng XR, Wang B, Yang WJ, Xie KJ.

Asian J Androl. 2013 Jan;15(1):129-33. doi: 10.1038/aja.2012.111. Epub 2012 Dec 10.

20.

Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients.

Suzuki H, Komiya A, Kamiya N, Imamoto T, Kawamura K, Miura J, Suzuki N, Nakatsu H, Hata A, Ichikawa T.

Urology. 2006 Jan;67(1):131-6.

PMID:
16413348
Items per page

Supplemental Content

Write to the Help Desk